Sentiss Pharma

Incorporated in 1990, Sentiss is committed to providing the best quality pharmaceutical products primarily in the Ophthalmic, ENT, and Inhalation segments. Over the past 25 years, by exhibiting commitment and showcasing our winning culture, Sentiss has evolved tremendously and is recognized as the third-best Ophthalmic Company (IMS 2015) in Russia. Sentiss’ footprint on the world map is a testimony to its quality philosophy and practice of product differentiation.

Sentiss strives to be a global leader in its core segment and continues to expand its operations in Russia, CIS, Europe, the USA, and Indian markets. Sentiss has a quality workforce of 700+ people across multiple geographies. Sentiss is recognized as one of the Top 100 Great Places to Work in India in 2015.

Since its inception in 1990, we have been continuously evolving and have crossed several milestones during this journey. Sentiss Research Centre (SRC) filed 50 patent applications out of which 9 patents have been granted till the end of Q2 2016.

Our key competitive advantage lies in having the R&D center together with the world-class manufacturing facility that has enabled us to provide end-to-end solutions from product development to marketing. Our manufacturing facility at Nalagarh (India) is EU GMP certified and TGA (Australia) approved. Sentiss is developing products for various countries. Over 1000 professionals in R&D, manufacturing, and sales & marketing are committed to delivering high-quality innovative products to customers.

Sentiss has forayed into the Indian market in October 2011 under the brand name PROVIS; by introducing a range of unique products through dedicated trained sales & marketing teams. Provis strives to redefine vision care in India by introducing unit dose preservative-free formulations. Provis has introduced products in disease segments like Dry Eye, Glaucoma, Ocular Nutrition, Allergy, Inflammation, and Infections through its dedicated team of sales and marketing professionals. Provis is expected to contribute significantly to the Indian eye care market.